Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Aim: To estimate the prevalence of Alzheimer’s disease (AD) and other dementias in the USA using a nationally representative sample. Methods: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. Results: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71–79 years to 37.4% of those aged 90 and older. Conclusions: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [316]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies suggest that racial and ethnic differences in dementia risk do not persist in rigorous analyses that account for health and socioeconomic factors.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [343]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“for example, EVs can induce ciliary signaling pathways and ciliogenesis, ciliary signaling can regulate vesicle release, and TNTs have been shown to transfer vesicles between cells [35,36].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 3×
“S.[3] The four previous national estimates of AD prevalence estimates differed by greater than two-fold and ranged from 2.”
BackgroundMethodRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“Currently accepted diagnostic criteria for subtypes of dementia were used.[19-21, 27] DSM criteria for dementia require memory impairment, however some subtypes of dementia do not present with prominent memory problems.”
MethodAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 2×
“5 million.[5,26] The lowest estimate came from a meta-analysis of 18 US and European studies; the highest from the East Boston and Chicago community studies.”
BackgroundBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“[2-6], all employing extrapolations from a few U.”
Method
Research works printed but not linked: 6
- Evans DA, Scherr PA, Cook NR, Albert MS, Funkenstein HH, Smith LA, Hebert LE, Wetle TT, Branch LG, Chown M, Hennekens CH, Taylor JO. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 1990;68:267–289. [PubMed] [Google Scholar]
- United States General Accounting Office . Alzheimer's Disease: Estimates of Prevalence in the United States. Washington: United States General Accounting Office; 1998. [Google Scholar]
- Willis RJ. Theory confronts data: how the HRS is shaped by the economics of aging and how the economics of aging will be shaped by the HRS. Labour Econ. 1999;6:119–145. [Google Scholar]
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington: American Psychiatric Association; 1987. [Google Scholar]
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122. doi: 10.1001/archneur.60.8.1119. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- 10.1001%2fjama.278.16.1349 · doi:10.1001/jama.278.16.1349 · Paper page
Cited by
Items 301–400 of 1,002
Shankar, K. N., Hirschman, K. B., Hanlon, A. L., & Naylor, M. D. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12657 · Cited by 85
Becerra, J., Fernández, T., Roca-Stappung, M., Díaz-Comas, L., Galán, L., Bosch, J., Espino, M., Moreno, A. J., & Harmony, T. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111055 · Cited by 90
“4% in those aged 90 and older in the USA [2].”
Pascual, B., Prieto, E., Arbizu, J., Martí-Climent, J. M., Olier, J., & Masdeu, J. C. (2010) · Stroke · doi:10.1161/strokeaha.110.591552 · Cited by 96
“The 4 groups included: (1) patients with AD; (2) patients with vascular disease and dementia; (3) patients with vascular disease but without dementia; and (4) healthy controls.”
BackgroundMethodVasilopoulos, T., Kotwal, A., Huisingh-Scheetz, M. J., Waite, L. J., McClintock, M. K., & Dale, W. (2014) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/gbu025 · Cited by 88
Chen, X., Clark, J. J., Chen, H., & Naorungroj, S. (2013) · Gerodontology · doi:10.1111/ger.12061 · Cited by 98
Memory impairment in aged primates is associated with region-specific network dysfunction
Thomé, A., Gray, D. T., Erickson, C. A., Lipa, P., & Barnes, C. A. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.160 · Cited by 92
Fink, H. A., Linskens, E. J., MacDonald, R., Silverman, P. C., McCarten, J. R., Talley, K. M. C., Forte, M. L., Desai, P. J., Nelson, V. A., Miller, M. A., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3887 · Cited by 83
Zhang, X., Hu, W., Wang, Y., Wang, W., Liao, H., Zhang, X., Kiburg, K., Shang, X., Bulloch, G., Huang, Y., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02449-3 · Cited by 91
Oxidative stress–mediated neuroinflammation in Alzheimer’s disease
Firdous, S. M., Khan, S. A., & Maity, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03188-3 · Cited by 98
“A nationally representative sample of individuals over 70 years old in the US was studied, and the prevalence of AD was found to be 9.7% (Plassman et al. 2007).”
InfluentialGlueckauf, R. L., Davis, W. S., Willis, F., Sharma, D., Gustafson, D. J., Hayes, J., Stutzman, M., Proctor, J., Kazmer, M. M., Murray, L., et al. (2012) · Rehabilitation Psychology · doi:10.1037/a0028688 · Cited by 87
Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study
Rodríguez‐Sánchez, E., Mora‐Simón, S., Patino-Alonso, M. C., García, R. G., Hernández, A. E., García‐Ortiz, L., Bartolomé, M. V. P., & Gómez-Marcos, M. Á. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-147 · Cited by 106
“Recent publications suggest that the number of individuals with CIND in the United States is about 70% higher than the number with dementia.”
InfluentialAction of estrogens in the aging brain: Dementia and cognitive aging
Henderson, V. W. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.11.005 · Cited by 99
“In the United States and Europe, Alzheimer's disease is by far the most common cause of dementia in old age [18,19].”
BackgroundPsychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA
Maust, D. T., Langa, K. M., Blow, F. C., & Kales, H. C. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4452 · Cited by 83
“Dementia affects a large and growing number of older adults (Plassman et al., 2007).”
BackgroundSelf-citationEffect of a Computerized Brain Exercise Program on Cognitive Performance in Older Adults
Miller, K. J., Dye, R. V., Kim, J., Jennings, J. L., O'Toole, E., Wong, J., & Siddarth, P. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.077 · Cited by 90
Dhana, K., Beck, T., Desai, P., Wilson, R. S., Evans, D. A., & Rajan, K. B. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13081 · Cited by 90
Demirtaş, M., Falcon, C., Tucholka, A., Gispert, J. D., Molinuevo, J. L., & Deco, G. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.08.006 · Cited by 89
Frailty and cognitive impairment as predictors of mortality in older Mexican Americans
Cano, C. A., Samper‐Ternent, R., Snih, S. A., Markides, K. S., & Ottenbacher, K. J. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0104-7 · Cited by 100
“Cognitive impairment also leads to loss of independence affecting individuals, families, and impacting the healthcare system [8].”
BackgroundMoore, A. H., Bigbee, M. J., Boynton, G. E., Wakeham, C. M., Rosenheim, H. M., Staral, C. J., Morrissey, J. L., & Hund, A. K. (2010) · Pharmaceuticals · doi:10.3390/ph3061812 · Cited by 86
“Alzheimer's disease, the most common cause of dementia [37], is a major public health concern.”
BackgroundLevine, D. A., Davydow, D. S., Hough, C. L., Langa, K. M., Rogers, M. A. M., & Iwashyna, T. J. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000008 · Cited by 93
“Thresholds for mild–moderate and moderate–severe cognitive impairment were based on HRS research and the methods used for the Aging, Demographics, and Memory Study,(25,26) and have been validated against neuropsychiatric interviews.(27)”
Self-citationMechanistic Link between Vitamin B12 and Alzheimer’s Disease
Lauer, A. A., Grimm, H. S., Apel, B., Golobrodska, N., Kruse, L., Ratanski, E., Schulten, N., Schwarze, L., Slawik, T., Sperlich, S., et al. (2022) · Publications of the UdS (Saarland University) · doi:10.22028/d291-35299 · Cited by 90
Predictors of dementia misclassification when using brief cognitive assessments
Ranson, J. M., Kuźma, E., Hamilton, W. T., Terrera, G. M., Langa, K. M., & Llewellyn, D. J. (2019) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000566 · Cited by 95
“9% population prevalence of dementia in US adults aged 70 and older.(35)”
BackgroundSelf-citationPotentially Unsafe Activities and Living Conditions of Older Adults with Dementia
Amjad, H., Roth, D. L., Samus, Q. M., Yasar, S., & Wolff, J. L. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14164 · Cited by 83
Plasma Klotho and Cognitive Decline in Older Adults: Findings From the InCHIANTI Study
Shardell, M., Semba, R. D., Rosano, C., Kalyani, R. R., Bandinelli, S., Chia, C. W., & Ferrucci, L. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv140 · Cited by 84
Han, L., Gill, T. M., Jones, B. L., & Allore, H. G. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv159 · Cited by 94
“9% of adults older than 70 years have some form of dementia (1,2).”
BackgroundFillenbaum, G. G., & Mohs, R. C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230026 · Cited by 89
“The ADAMS eight-year study of prevalence and incidence of dementia is the first, and to date only nationally representative survey of dementia in the U.S. [130, 131].”
Davydow, D. S., Zatzick, D., Hough, C. L., & Katon, W. J. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201303-060oc · Cited by 91
Dysphagia in Alzheimer's disease
Seçıl, Y., Arıcı, Ş., İncesu, T. K., Gürgör, N., Beckmann, Y. Y., & Ertekin, C. (2016) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2015.12.007 · Cited by 91
Age-Associated Financial Vulnerability: An Emerging Public Health Issue
Lachs, M. S., & Han, S. D. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0882 · Cited by 75
“V processes common in the aging brain may affect an older adult's ability to manage personal finances, the most recognized of which are dementing illnesses (1).”
BackgroundDementia Prevalence in Greece: The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD)
Kosmidis, M. H., Vlachos, G. S., Anastasiou, C. A., Yannakoulia, M., Dardiotis, E., Hadjigeorgiou, G. M., Sakka, P., Ntanasi, E., & Scarmeas, N. (2018) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000249 · Cited by 97
Trends in inequalities in the prevalence of dementia in the United States
Hudomiet, P., Hurd, M. D., & Rohwedder, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212205119 · Cited by 83
Self-citationHenderson, V. W., & Brinton, R. D. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82003-5 · Cited by 79
“Alzheimer’s disease, by far the most common cause of dementia occurring later in life, affects an estimated 2.5–4.5 million older Americans (Hebert et al., 2003; Plassman et al., 2007).”
BackgroundInfluentialPrevalence and correlates of cognitive impairment in a north Indian elderly population
Sengupta, P., Benjamin, A., Singh, Y., & Grover, A. (2014) · WHO South-East Asia Journal of Public Health · doi:10.4103/2224-3151.206729 · Cited by 92
Deep brain stimulation for Alzheimer's Disease: An update
Hescham, S., Aldehri, M., Temel, Y., Alnaami, I., & Jahanshahi, A. (2018) · Surgical Neurology International · doi:10.4103/sni.sni_342_17 · Cited by 82
“Dementia is a serious socioeconomic threat for ageing societies.[24,30] The mean life expectancy after diagnosis of AD is approximately 7 years.”
BackgroundAssociation between APOE ε4 Allele and Vascular Dementia: The Cache County Study
Chuang, Y.-F., Hayden, K. M., Norton, M. C., Tschanz, J., Breitner, J. C. S., Welsh-Bohmer, K. A., Zandi, P. P., & for the Cache County Investigators (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000285166 · Cited by 81
“Vascular dementia (VaD) is one of the most common forms of dementia, second only to Alzheimer’s disease (AD). In 2002, the estimated prevalence of VaD among individuals aged 71 years and older in the USA was 2.4p, compared to 9.7p for AD [”
BackgroundDeveloping the Resilience Framework for Nursing and Healthcare
Morse, J. M., Kent‐Marvick, J., Barry, L. A., Harvey, J., Okang, E. N., Rudd, E., Wang, C., & Williams, M. (2021) · Global Qualitative Nursing Research · doi:10.1177/23333936211005475 · Cited by 89
“Persons with Alzheimer’s will experience declines in cognitive functions which ultimately impact their ability to carry out activities of daily living (ADLs), resulting in their dependence on formal or, more often, informal caregivers (Plassman et al., 2007).”
BackgroundMidlife predictors of Alzheimer's disease
Bendlin, B. B., Carlsson, C. M., Gleason, C. E., Johnson, S. C., Sodhi, A., Gallagher, C. L., Puglielli, L., Engelman, C. D., Ries, M. L., Xu, G., et al. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.12.014 · Cited by 78
“[2] Plassman BL, Langa KM, Fisher GG, et al.”
Neighborhood environment and cognitive function in older adults: A multilevel analysis in Hong Kong
Guo, Y., Chan, C. H., Chang, Q., Liu, T., & YIP, P. S. F. (2019) · Health & Place · doi:10.1016/j.healthplace.2019.102146 · Cited by 85
Guidelines for Psychological Practice with Older Adults
(2013) · PsycEXTRA Dataset · doi:10.1037/e645272013-001 · Cited by 81
When and How to use Multiple Informants to Improve Clinical Assessments
Alexander, L. A., McKnight, P. E., Disabato, D. J., & Kashdan, T. B. (2017) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-017-9607-9 · Cited by 81
“The prevalence rates for dementia in 71 year-old females is 4.76% versus 27.84% in 81 year-old females (Plassman et al. 2007).”
BackgroundInfluentialO-GlcNAcylation as a Therapeutic Target for Alzheimer’s Disease
Park, J., Lai, M. K. P., Arumugam, T. V., & Jo, D. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08584-0 · Cited by 85
Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study
Gavrila, D., Antúnez, C., Tormo, M. J., Carles, R., García Santos, J. M., Parrilla, G., Fortuna, L., Jiménez, J., Salmerón, D., & Navarro, C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01283.x · Cited by 76
“Nevertheless, a similar result was obtained in the Aging, Demographics and Memory Study on the prevalence of dementia in the United States (42).”
ResultDeep brain stimulation in dementia-related disorders
Hescham, S., Lim, L. W., Jahanshahi, A., Blokland, A., & Temel, Y. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.002 · Cited by 85
Graff‐Radford, N. R., & Jones, D. T. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000689 · Cited by 98
Fowler, N. R., Perkins, A. J., Gao, S., Sachs, G. A., & Boustani, M. A. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16247 · Cited by 79
Yunusa, I. U., & Helou, M. L. E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00596 · Cited by 81
Evaluating Driving as a Valued Instrumental Activity of Daily Living
Dickerson, A. E., Reistetter, T., Davis, E. S., & Monahan, M. (2011) · American Journal of Occupational Therapy · doi:10.5014/ajot.2011.09052 · Cited by 86
Prevalence of dementia in the oldest old: The Monzino 80‐plus population based study
Lucca, U., Tettamanti, M., Logroscino, G., Tiraboschi, P., Landi, C., Sacco, L., Garrì, M., Ammesso, S., Bertinotti, C., Biotti, A., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1750 · Cited by 71
The economics of mild cognitive impairment
Lin, P., & Neumann, P. J. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.05.2117 · Cited by 71
“[50] Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al.”
BackgroundMethodAtrial fibrillation, cognitive impairment, and neuroimaging
Graff‐Radford, J., Madhavan, M., Vemuri, P., Rabinstein, A. A., Cha, R. H., Mielke, M. M., Kantarci, K., Lowe, V. J., Senjem, M. L., Gunter, J. L., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.08.164 · Cited by 84
“9% [2]; (10% in Mayo Clinic Study of Aging [MCSA]) [3].”
BackgroundGeerts, H., Dacks, P. A., Devanarayan, V., Haas, M., Khachaturian, Z. S., Gordon, M. F., Maudsley, S., Romero, K., Stephenson, D., & (BHMI), B. H. M. I. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.008 · Cited by 79
Smooth muscle cells of intracranial vessels: from development to disease
Frösén, J., & Joutel, A. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy002 · Cited by 84
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease
Alzheimer's Association National Plan Milestone Workgroup, Fargo, K. N., Aisen, P., Albert, M., Au, R., Corrada, M. M., DeKosky, S., Drachman, D., Fillit, H., Gitlin, L., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.08.103 · Cited by 76
“Recruitment of participants from underrepresented populations has proven particularly difficult, despite the fact that studies report higher Alzheimer’s risk among both African-Americans and Hispanics [40–44].”
ResultSelf-citationMediterranean diet and cognitive health: an update of available knowledge
Feart, C., Samieri, C., & Barberger-Gateau, P. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000131 · Cited by 73
“0% in the age group 65–69 years to 30% in the older than 90 years age group [2].”
BackgroundThe effect of telemedicine on cognitive decline in patients with dementia
Kim, H. S., Jhoo, J. H., & Jang, J. (2016) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x15615049 · Cited by 79
Strout, K. A., David, D., Dyer, E. J., Gray, R. C., Robnett, R. H., & Howard, E. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14129 · Cited by 81
“Risk of cognitive decline increases significantly with age.(6) Adults in their 90s are 75% more likely to demonstrate symptoms of decline than those in their 70s,(6) although cognitive decline is not a direct consequence of aging.”
BackgroundFowler, N. R., Partrick, K. A., Taylor, J. O., Hornbecker, M., Kelleher, K., Boustani, M. A., Cummings, J. L., MacLeod, T., Mielke, M. M., Brosch, J. R., et al. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20098 · Cited by 84
“Approximately 14% of older adults have ADRD [5], and up to 20% have MCI in the United States (US).”
Depressive Symptoms in Oldest-Old Women: Risk of Mild Cognitive Impairment and Dementia
Spira, A. P., Rebok, G. W., Stone, K. L., Kramer, J. H., & Yaffe, K. (2012) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318235b611 · Cited by 73
“Cognitive impairment also is common among elders; 14% of adults over 70 years and 37% of those over 90 have dementia.(5) At least as many older adults are thought to have mild cognitive impairment (MCI).”
BackgroundA roadmap for the prevention of dementia II: Leon Thal Symposium 2008
Khachaturian, Z. S. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.021 · Cited by 77
“2 million Americans have Alzheimer’s disease (AD) [1,2], and this number is expected to increase to as many as 7.”
Spira, A. P., Stone, K. L., Redline, S. S., Ensrud, K. E., Ancoli‐Israel, S., Cauley, J. A., & Yaffe, K. S. (2017) · SLEEP · doi:10.1093/sleep/zsx073 · Cited by 82
“INTRODUCTION Cognitive impairment is common in the rapidly growing US population of older adults, with about one-third of adults aged 71 and older meeting criteria for mild cognitive impairment (MCI) or dementia.(1,2) Sleep disturbances also are prevalent among older people; more than half of those aged 65 and older h…”
Oh, E. S., & Rabins, P. V. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201909030 · Cited by 80
Oral health in nursing home residents with different cognitive statuses
Chen, X., Clark, J. J. J., & Naorungroj, S. (2012) · Gerodontology · doi:10.1111/j.1741-2358.2012.00644.x · Cited by 87
Meyer, M. L., Palta, P., Tanaka, H., Deal, J. A., Wright, J. D., Knopman, D. S., Griswold, M. E., Mosley, T. H., & HEISS, G. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161041 · Cited by 76
Is sporadic Alzheimer′s disease a developmental disorder?
Arendt, T., Stieler, J., & Ueberham, U. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14036 · Cited by 77
The Role of the Thioredoxin System in Brain Diseases
Bjørklund, G., Zou, L., Peana, M., Chasapis, C. T., Hangan, T., Lu, J., & Maes, M. H. J. (2022) · Antioxidants · doi:10.3390/antiox11112161 · Cited by 76
“Alzheimer’s disease (AD) is the most critical neurodegenerative disorder of the central nervous system, accounting for more than 60–80% of all dementia cases [17,72] and is a severe healthcare challenge in developed countries in elderly individuals [73,74].”
BackgroundEffect of Patient Perceptions on Dementia Screening in Primary Care
Fowler, N. R., Boustani, M. A., Frame, A., Perkins, A. J., Monahan, P., Gao, S., Sachs, G. A., & Hendrie, H. C. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03991.x · Cited by 71
“Key words: dementia screening; patient perception; dementia; older adults Dementia is a debilitating, degenerative neurologicalcondition that affects approximately 4.5 million people in the United States.1 There is no cure for dementia, and the latest recommendation by the United States Preventive Services Task Force2…”
BackgroundInfluentialNuttall, J. R., & Oteiza, P. I. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0379-x · Cited by 79
“Among the various forms of dementia, Alzheimer's disease (AD) is the most common affecting nearly 10 % of the population in the United States over 70 years of age (Plassman et al. 2007).”
Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States
Wilson, R. S., Weir, D. R., Leurgans, S. E., Evans, D. A., Hebert, L. E., Langa, K. M., Plassman, B. L., Small, B. J., & Bennett, D. A. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.11.006 · Cited by 74
“We reviewed several differences between the Hebert et al [3] and Plassman et al [6] studies that could have affected results.”
MethodResultInfluentialSelf-citationPrevalence of Cognitive Impairment Without Dementia and Dementia in Tremembé, Brazil
César, K. G., Brucki, S. M. D., Takada, L. T., Nascimento, L. F. C., Gomes, C. M. S., Almeida, M. C. S., Oliveira, M. O., Porto, F. H. G., Senaha, M. L. H., Bahia, V. S., et al. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000122 · Cited by 72
Lu, K. P., Kondo, A., Albayram, Ö., Herbert, M. K., Liu, H., & Zhou, X. Z. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2027 · Cited by 78
Volunteering Is Associated with Lower Risk of Cognitive Impairment
Infurna, F. J., Okun, M. A., & Grimm, K. J. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14398 · Cited by 68
“Participants aged 60 and older in 1998 were included because they were administered all of the measures used to create the cognitive impairment score.(34) Figure 1 illustrates participant selection for the present study and the number who became cognitively impaired.”
MethodOlder patients are still under-represented in clinical trials of Alzheimer's disease
Banzi, R., Camaioni, P., Tettamanti, M., Bertele’, V., & Lucca, U. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0201-2 · Cited by 74
“Thus, to retrieve Alzheimer’s disease prevalence estimates by 5 year classes, we referred to published and unpublished data from previous cohort studies [17, 18].”
BackgroundMethodInfluentialHarris, D. P., Chodosh, J., Vassar, S. D., Vickrey, B. G., & Shapiro, M. F. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02572.x · Cited by 74
“2 million suffer from dementia.(2) Despite increasing prevalence and frequency of older patient visits to primary care providers (PCPs), dementia detection in primary care is low, and quality of care for dementia is lower than that for other common conditions.”
BackgroundTon, T. G. N., DeLeire, T., May, S. G., Hou, N., Tebeka, M. G., Chen, E., & Chodosh, J. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.08.009 · Cited by 80
“As such, our study provides results are weighted to represent adults ages 70 years and older in the United States while maintaining a clinical gold standard of diagnosis.”
MethodInfluentialSex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data
Zhu, Y., Chen, Y., Crimmins, E. M., & Zissimopoulos, J. M. (2021) · The Journals of Gerontology: Series B · doi:10.1093/geronb/gbaa083 · Cited by 72
“Sample sizes, however, are small and the study has not been repeated over time (Crimmins et al., 2011; Plassman et al., 2007).”
BackgroundKetogenic Diet for the Treatment and Prevention of Dementia: A Review
Davis, J. J., Fournakis, N. A., & Ellison, J. M. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720901785 · Cited by 77
Dementia Risk and Financial Decision Making by Older Households: The Impact of Information
Hsu, J. W., & Willis, R. J. (2013) · Journal of Human Capital · doi:10.1086/674105 · Cited by 80
Self-citationYe, C. Y., Lei, Y., Tang, X. C., & Zhang, H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.020 · Cited by 76
Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer
Mohile, S. G., Lacy, M. A., Rodin, M. B., Bylow, K. A., Dale, W., Meager, M. R., & Stadler, W. M. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.06.009 · Cited by 73
“Further exploration determined that 45% met the psychometric criteria for dementia, with a profile of memory impairment and often executive deficits [8].”
BackgroundAndersen, F., Viitanen, M., Halvorsen, D. S., Straume, B., & Engstad, T. A. (2011) · BMC Geriatrics · doi:10.1186/1471-2318-11-58 · Cited by 71
“In particular, this is true for Alzheimer’s disease (AD), constituting 65 - 70% of all dementia subtypes, inflicting an extensive and serious impact on activities of daily living and quality of life for patients and their caregivers [1-5].”
BackgroundSchneider, A. L. C., Sharrett, A. R., Gottesman, R. F., Coresh, J., Coker, L., Wruck, L., Selnes, O. A., Deal, J., Knopman, D., & Mosley, T. H. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000042 · Cited by 68
“Of the 1134 participants who attended the ARIC Brain MRI visit, we excluded (1) 101 participants with clinical neurological disease.”
BackgroundInfluentialStothart, G., Kazanina, N., Näätänen, R., Haworth, J., & Tales, A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140930 · Cited by 76
“[1, 2].”
d’Abramo, C., D'adamio, L., & Giliberto, L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030116 · Cited by 79
Reassessment of Pioglitazone for Alzheimer’s Disease
Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 63
Smith, E. E., Aparicio, H. J., Gottesman, R. F., Goyal, M. S., Greenberg, S. M., Schneider, J. A., Sorond, F. A., & Wright, C. B. (2025) · Stroke · doi:10.1161/str.0000000000000494 · Cited by 82
The Relationship Between Physical Activity and Cognition in Older Latinos
Wilbur, J. E., Márquez, D. X., Fogg, L., Wilson, R. S., Staffileno, B. A., Hoyem, R. L., Morris, M. C., Bustamante, E. E., & Manning, A. (2012) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbr137 · Cited by 81
Parental Education and Late-life Dementia in the United States
Rogers, M. A. M., Plassman, B. L., Kabeto, M., Fisher, G. G., McArdle, J. J., Llewellyn, D. J., Potter, G. G., & Langa, K. M. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988708328220 · Cited by 67
“Further details of subcategories of dementia and CIND have been described elsewhere.(8,10) Information regarding father’s education and mother’s education was based on self- or proxyreported information collected during the baseline HRS interview.”
Self-citationIdentification of community‐residing individuals with dementia and their unmet needs for care
Johnston, D., Samus, Q. M., Morrison, A., Leoutsakos, J. S., Hicks, K., Handel, S., Rye, R., Robbins, B., Rabins, P. V., Lyketsos, C. G., et al. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2527 · Cited by 71
The Care Ecosystem: Promoting self-efficacy among dementia family caregivers
Merrilees, J. J., Bernstein, A., Dulaney, S., Heunis, J., Walker, R., Rah, E., Choi, J., Gawlas, K., Carroll, S., Ong, P., et al. (2020) · Dementia · doi:10.1177/1471301218814121 · Cited by 63
Developing Dementia-Friendly Tourism Destinations: An Exploratory Analysis
Page, S. J., Innes, A., & Cutler, C. (2014) · Journal of Travel Research · doi:10.1177/0047287514522881 · Cited by 71
“For example, there are 820,000 people with dementia living in the United Kingdom (Luengo-Fernandez, Leal, and Gray 2010) and more than 3 million in the USA (Plassman et al. 2007), with 35.6 million people with dementia worldwide.”
BackgroundInfluentialTauopathy and neurodegeneration: A role for stress
Sierra-Fonseca, J. A., & Gosselink, K. L. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.08.009 · Cited by 73
“AD is the most prevalent neurodegenerative disease worldwide, estimated to affect approximately 10% of the population over 70 years old and with increasing incidence expected in the coming years (Plassman et al., 2007).”
BackgroundGroppell, S., Soto‐Ruiz, K. M., Flores, B., Dawkins, W., Smith, I., Eagleman, D. M., & Katz, Y. (2019) · JMIR Aging · doi:10.2196/12615 · Cited by 73
“Concordantly, by 2030 the incidence of dementia is projected to increase from 35 million to 70 million [2].”
BackgroundCentenarian Studies: Important Contributors to Our Understanding of the Aging Process and Longevity
Willcox, D. C., Willcox, B. J., & Poon, L. W. (2010) · Current Gerontology and Geriatrics Research · doi:10.1155/2010/484529 · Cited by 78
Tsolaki, A. C., Kosmidou, V., Kompatsiaris, I. (., Papadaniil, C., Hadjileontiadis, L., Adam, A., & Tsolaki, M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.025 · Cited by 70
“The most common cause of dementia is Alzheimer's disease (AD) (Plassman et al., 2007).”
Glueckauf, R. L., Davis, W. S., Allen, K., Chipi, P., Schettini, G., Tegen, L., Xu, J., Gustafson, D. J., Maze, J., Mosser, B., et al. (2009) · Rehabilitation Psychology · doi:10.1037/a0017855 · Cited by 71
2026 Alzheimer's disease facts and figures
(2026) · Alzheimer s & Dementia · doi:10.1002/alz.71345 · Cited by 118
Calibration and Validation of an Innovative Approach for Estimating General Cognitive Performance
Gross, A. L., Jones, R. N., Fong, T. G., Tommet, D., & Inouye, S. K. (2014) · Neuroepidemiology · doi:10.1159/000357647 · Cited by 71
“Clinical diagnoses—Clinical diagnoses, grouped as normal cognitive function, cognitive impairment-no dementia (CIND), and all-cause dementia, were assigned in ADAMS by an expert clinical consensus panel (14,17).”
Bowen, M. E. (2012) · American Journal of Health Promotion · doi:10.4278/ajhp.110311-quan-115 · Cited by 63
Ehrlich, J. R., Goldstein, J., Swenor, B. K., Whitson, H., Langa, K. M., & Veliz, P. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0723 · Cited by 69
Self-citationMielke, M. M. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2019.030023 · Cited by 63
“As a result, and similar to other aging-related diseases, the lifetime risk of AD dementia is greater for women (4, 5).”
BackgroundVitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC B rain MRI Study
Schneider, A. L. C., Lutsey, P. L., Alonso, Á., Gottesman, R. F., Sharrett, A. R., Carson, K. A., Gross, M., Post, W. S., Knopman, D. S., Mosley, T. H., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12460 · Cited by 69
“Vitamin D insufficiency and deficiency are more prevalent amongst older individuals [2], as are cognitive impairment and dementia [29].”
Background
Metadata
- Authors
- Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., Steffens, D. C., Willis, R. J., & Wallace, R. B.
- Affiliations
- Duke University (US)
- University of Michigan (US)
- Duke Medical Center (US)
- RAND Corporation (US)
- University of Iowa (US)
- ORCID
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 29
- Issue
- 1-2
- Pages
- 125-132
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- PMC
- PMC2705925
- OpenAlex
- W2133488570
- Cited by
- 1,932
- References
- 44
- Citations by year
- 2026: 36 · 2025: 77 · 2024: 68 · 2023: 76 · 2022: 109 · 2021: 144 · 2020: 152 · 2019: 108 · 2018: 107 · 2017: 111 · 2016: 122 · 2015: 123 · 2014: 153 · 2013: 126 · 2012: 121
- FWCI
- 38.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroepidemiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K08AG019180, U01 AG 09740, U01AG009740)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- dementia prevalence, Alzheimer's disease, vascular dementia, older adults, cognitive impairment, age differences, sex differences, population aging, health planning
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Health Surveys, Humans, Male, United States, Cohort Studies, Geriatric Assessment, Prevalence, Logistic Models, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.